Current Perspectives in Bladder Cancer Management
Current Perspectives in Bladder Cancer Management
A single episode of VH is a warning sign that needs prompt investigation and urological referral. This is a key message for both the public and doctors in Primary Care. Symptoms attributable to bladder cancer can mimic UTI. Failure to respond to antibiotics following a symptomatic UTI or an early recurrent UTI warrants flexible cystoscopic evaluation before considering repeat courses of antibiotics. Otherwise, diagnosis (particularly in postmenopausal women) is delayed and may be contributory to less favourable outcomes in women than men. It is important to get this message across to doctors in Primary Care and pharmacists.
Until recently, bladder cancer has been low on the public health agenda. However, the Department of Health has recognised the need for earlier diagnosis of bladder cancer, and has commenced a pilot study in three regions of the UK to determine the best way to promote these messages.
Action on Bladder Cancer (http://www.actiononbladdercancer.org) is the only UK national bladder cancer charity purely focussed on improving the lives of patients with bladder cancer. It has three primary aims, namely to: improve awareness; elevate the status of bladder cancer in the public health agenda; and improve medical knowledge. It is hoped that the website will provide a good resource for the general public, patients and healthcare professionals.
Can Public and Professional Recognition of Bladder Cancer Be Improved?
A single episode of VH is a warning sign that needs prompt investigation and urological referral. This is a key message for both the public and doctors in Primary Care. Symptoms attributable to bladder cancer can mimic UTI. Failure to respond to antibiotics following a symptomatic UTI or an early recurrent UTI warrants flexible cystoscopic evaluation before considering repeat courses of antibiotics. Otherwise, diagnosis (particularly in postmenopausal women) is delayed and may be contributory to less favourable outcomes in women than men. It is important to get this message across to doctors in Primary Care and pharmacists.
Until recently, bladder cancer has been low on the public health agenda. However, the Department of Health has recognised the need for earlier diagnosis of bladder cancer, and has commenced a pilot study in three regions of the UK to determine the best way to promote these messages.
Action on Bladder Cancer (http://www.actiononbladdercancer.org) is the only UK national bladder cancer charity purely focussed on improving the lives of patients with bladder cancer. It has three primary aims, namely to: improve awareness; elevate the status of bladder cancer in the public health agenda; and improve medical knowledge. It is hoped that the website will provide a good resource for the general public, patients and healthcare professionals.
Source...